Advances in targeting of miR‑10‑associated lncRNAs/circRNAs for the management of cancer (Review)
- Authors:
- Shengyu Gao
- Shuang Liu
- Weiwei Wei
- Yanxiu Qi
- Fanshi Meng
-
Affiliations: School of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang 154002, P.R. China, Department of General Surgery I, The First Affiliated Hospital of Jiamusi University, Jiamusi, Heilongjiang 154002, P.R. China - Published online on: January 19, 2023 https://doi.org/10.3892/ol.2023.13675
- Article Number: 89
-
Copyright: © Gao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
Deo SVS, Sharma J and Kumar S: GLOBOCAN 2020 report on global cancer burden: Challenges and opportunities for surgical oncologists. Ann Surg Oncol. 29:6497–6500. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Xia C, Dong X, Li H, Cao M, Sun D, He S, Yang F, Yan X, Zhang S, Li N and Chen W: Cancer statistics in China and United States, 2022: Profiles, trends, and determinants. Chin Med J (Engl). 135:584–590. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Wei C, Zhao L, Liang H, Zhen Y and Han L: Recent advances in unraveling the molecular mechanisms and functions of HOXA11-AS in human cancers and other diseases (review). Oncol Rep. 43:1737–1754. 2020.PubMed/NCBI | |
|
Mao M, Zhang J, Xiang Y, Gong M, Deng Y and Ye D: Role of exosomal competitive endogenous RNA (ceRNA) in diagnosis and treatment of malignant tumors. Bioengineered. 13:12156–12168. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Bhan A, Soleimani M and Mandal SS: Long noncoding RNA and Cancer: A new paradigm. Cancer Res. 77:3965–3981. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ye J, Li J and Zhao P: Roles of ncRNAs as ceRNAs in gastric cancer. Genes (Basel). 12:10362021. View Article : Google Scholar : PubMed/NCBI | |
|
Lee YR and Pandolfi PP: PTEN mouse models of cancer initiation and progression. Cold Spring Harb Perspect Med. 10:a0372832020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang J, Zhu S, Meng N, He Y, Lu R and Yan GR: ncRNA-encoded peptides or proteins and cancer. Mol Ther. 27:1718–1725. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Liu C, Wu Y and Ma J: Interaction of non-coding RNAs and Hippo signaling: Implications for tumorigenesis. Cancer Lett. 493:207–216. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Slack FJ and Chinnaiyan AM: The role of non-coding RNAs in oncology. Cell. 179:1033–1055. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Anastasiadou E, Jacob LS and Slack FJ: Non-coding RNA networks in cancer. Nat Rev Cancer. 18:5–18. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang J, Li K, Zheng H and Zhu Y: Research progress review on long non-coding RNA in colorectal cancer. Neoplasma. 68:240–252. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Basera A, Hull R, Demetriou D, Bates DO, Kaufmann AM, Dlamini Z and Marima R: Competing endogenous RNA (ceRNA) networks and splicing switches in cervical cancer: HPV oncogenesis, clinical significance and therapeutic opportunities. Microorganisms. 10:18522022. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, Khan S, Li L, Ten Hagen TLM and Falahati M: Molecular mechanisms of thyroid cancer: A competing endogenous RNA (ceRNA) point of view. Biomed Pharmacother. 146:1122512022. View Article : Google Scholar : PubMed/NCBI | |
|
Liu H, Deng H, Zhao Y, Li C and Liang Y: LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling. J Exp Clin Cancer Res. 37:2792018. View Article : Google Scholar : PubMed/NCBI | |
|
Lima CR, Geraldo MV, Fuziwara CS, Kimura ET and Santos MF: MiRNA-146b-5p upregulates migration and invasion of different Papillary thyroid carcinoma cells. BMC Cancer. 16:1082016. View Article : Google Scholar : PubMed/NCBI | |
|
Worst TS, Previti C, Nitschke K, Diessl N, Gross JC, Hoffmann L, Frey L, Thomas V, Kahlert C, Bieback K, et al: miR-10a-5p and miR-29b-3p as extracellular vesicle-associated prostate cancer detection markers. Cancers (Basel). 12:432019. View Article : Google Scholar : PubMed/NCBI | |
|
Wang J, Wang B, Chen LQ, Yang J, Gong ZQ, Zhao XL, Zhang CQ and Du KL: miR-10b promotes invasion by targeting KLF4 in osteosarcoma cells. Biomed Pharmacother. 84:947–953. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu H, Kang M and Bai X: TCF21 regulates miR-10a-5p/LIN28B signaling to block the proliferation and invasion of melanoma cells. PLoS One. 16:e02559712021. View Article : Google Scholar : PubMed/NCBI | |
|
Wang L, Cho KB, Li Y, Tao G, Xie Z and Guo B: Long noncoding RNA (lncRNA)-mediated competing endogenous RNA networks provide novel potential biomarkers and therapeutic targets for colorectal cancer. Int J Mol Sci. 20:57582019. View Article : Google Scholar : PubMed/NCBI | |
|
Xing C, Sun SG, Yue ZQ and Bai F: Role of lncRNA LUCAT1 in cancer. Biomed Pharmacother. 134:1111582021. View Article : Google Scholar : PubMed/NCBI | |
|
Tan YT, Lin JF, Li T, Li JJ, Xu RH and Ju HQ: LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun (Lond). 41:109–120. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Peng WX, Koirala P and Mo YY: LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Tang X, Ren H, Guo M, Qian J, Yang Y and Gu C: Review on circular RNAs and new insights into their roles in cancer. Comput Struct Biotechnol J. 19:910–928. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Chen L, Wang C, Sun H, Wang J, Liang Y, Wang Y and Wong G: The bioinformatics toolbox for circRNA discovery and analysis. Brief Bioinform. 22:1706–1728. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Wu P, Mo Y, Peng M, Tang T, Zhong Y, Deng X, Xiong F, Guo C, Wu X, Li Y, et al: Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA. Mol Cancer. 19:222020. View Article : Google Scholar : PubMed/NCBI | |
|
Yu T, Wang Y, Fan Y, Fang N, Wang T, Xu T and Shu Y: CircRNAs in cancer metabolism: A review. J Hematol Oncol. 12:902019. View Article : Google Scholar : PubMed/NCBI | |
|
Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M, et al: Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Kong S, Tao M, Shen X and Ju S: Translatable circRNAs and lncRNAs: Driving mechanisms and functions of their translation products. Cancer Lett. 483:59–65. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function as efficient microRNA sponges. Nature. 495:384–388. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Saliminejad K, Khorram Khorshid HR, Soleymani Fard S and Ghaffari SH: An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. J Cell Physiol. 234:5451–5465. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Wang S, Talukder A, Cha M, Li X and Hu H: Computational annotation of miRNA transcription start sites. Brief Bioinform. 22:380–392. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Ali Syeda Z, Langden SSS, Munkhzul C, Lee M and Song SJ: Regulatory mechanism of MicroRNA expression in cancer. Int J Mol Sci. 21:17232020. View Article : Google Scholar : PubMed/NCBI | |
|
Catalanotto C, Cogoni C and Zardo G: MicroRNA in control of gene expression: An overview of nuclear functions. Int J Mol Sci. 17:17122016. View Article : Google Scholar : PubMed/NCBI | |
|
He B, Zhao Z, Cai Q, Zhang Y, Zhang P, Shi S, Xie H, Peng X, Yin W, Tao Y and Wang X: miRNA-based biomarkers, therapies, and resistance in Cancer. Int J Biol Sci. 16:2628–2647. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao Z, Sun W, Guo Z, Zhang J, Yu H and Liu B: Mechanisms of lncRNA/microRNA interactions in angiogenesis. Life Sci. 254:1169002020. View Article : Google Scholar : PubMed/NCBI | |
|
Yang L, Sun HF, Guo LQ and Cao HB: MiR-10a-5p: A promising biomarker for early diagnosis and prognosis evaluation of bladder cancer. Cancer Manag Res. 13:7841–7850. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Han TS, Hur K, Cho HS and Ban HS: Epigenetic associations between lncRNA/circRNA and miRNA in hepatocellular carcinoma. Cancers (Basel). 12:26222020. View Article : Google Scholar : PubMed/NCBI | |
|
Qi X, Zhang DH, Wu N, Xiao JH, Wang X and Ma W: ceRNA in cancer: Possible functions and clinical implications. J Med Genet. 52:710–718. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu J, Zhang X, Gao W, Hu H, Wang X and Hao D: lncRNA/circRNA-miRNA-mRNA ceRNA network in lumbar intervertebral disc degeneration. Mol Med Rep. 20:3160–3174. 2019.PubMed/NCBI | |
|
Cheng Y, Su Y, Wang S, Liu Y, Jin L, Wan Q, Liu Y, Li C, Sang X, Yang L, et al: Identification of circRNA-lncRNA-miRNA-mRNA competitive endogenous RNA network as novel prognostic markers for acute myeloid leukemia. Genes (Basel). 11:8682020. View Article : Google Scholar : PubMed/NCBI | |
|
Salmena L, Poliseno L, Tay Y, Kats L and Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Moreno-Garcia L, López-Royo T, Calvo AC, Toivonen JM, de la Torre M, Moreno-Martínez L, Molina N, Aparicio P, Zaragoza P, Manzano R and Osta R: Competing endogenous RNA networks as biomarkers in neurodegenerative diseases. Int J Mol Sci. 21:95822020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou T, Lin K, Nie J, Pan B, He B, Pan Y, Sun H, Xu T and Wang S: LncRNA SPINT1-AS1 promotes breast cancer proliferation and metastasis by sponging let-7 a/b/i-5p. Pathol Res Pract. 217:1532682021. View Article : Google Scholar : PubMed/NCBI | |
|
Tajima H, Kumazaki T, Gemma K, Iida E, Kawamata H, Murakami R, Goto S and Aoyama T: Rotational digital angiography of ulcer-like projection of pelvis. Radiat Med. 14:49–51. 1996.PubMed/NCBI | |
|
Li C, Mu J, Shi Y and Xin H: LncRNA CCDC26 interacts with CELF2 protein to enhance myeloid leukemia cell proliferation and invasion via the circRNA_ANKIB1/miR-195-5p/PRR11 axis. Cell Transplant. 30:9636897209860802021. View Article : Google Scholar : PubMed/NCBI | |
|
Zeng X, Xiao J, Bai X, Liu Y, Zhang M, Liu J, Lin Z and Zhang Z: Research progress on the circRNA/lncRNA-miRNA-mRNA axis in gastric cancer. Pathol Res Pract. 238:1540302022. View Article : Google Scholar : PubMed/NCBI | |
|
Cao J, Zhang M, Zhang L, Lou J, Zhou F and Fang M: Non-coding RNA in thyroid cancer-functions and mechanisms. Cancer Lett. 496:117–126. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Tehler D, Hoyland-Kroghsbo NM and Lund AH: The miR-10 microRNA precursor family. RNA Biol. 8:728–734. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Liu F, Shi Y, Liu Z, Li Z and Xu W: The emerging role of miR-10 family in gastric cancer. Cell Cycle. 20:1468–1476. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Guo L, Li Y, Zhao C, Peng J, Song K, Chen L, Zhang P, Ma H, Yuan C, Yan S, et al: RECQL4, negatively regulated by miR-10a-5p, facilitates cell proliferation and invasion via MAFB in ovarian cancer. Front Oncol. 10:5241282020. View Article : Google Scholar : PubMed/NCBI | |
|
Lu Y, Wei G, Liu L, Mo Y, Chen Q, Xu L, Liao R, Zeng D and Zhang K: Direct targeting of MAPK8IP1 by miR-10a-5p is a major mechanism for gastric cancer metastasis. Oncol Lett. 13:1131–1136. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu J, Du S, Zhang J, Huang G, Dong L, Ren E and Liu D: microRNA-10a-5p from gastric cancer cell-derived exosomes enhances viability and migration of human umbilical vein endothelial cells by targeting zinc finger MYND-type containing 11. Bioengineered. 13:496–507. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Vu TT, Stölzel F, Wang KW, Röllig C, Tursky ML, Molloy TJ and Ma DD: miR-10a as a therapeutic target and predictive biomarker for MDM2 inhibition in acute myeloid leukemia. Leukemia. 35:1933–1948. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Kuratomi N, Takano S, Fukasawa M, Maekawa S, Kadokura M, Shindo H, Takahashi E, Hirose S, Fukasawa Y, Kawakami S, et al: MiR-10a in pancreatic juice as a biomarker for invasive intraductal papillary mucinous neoplasm by miRNA sequencing. Int J Mol Sci. 22:32212021. View Article : Google Scholar : PubMed/NCBI | |
|
Thai AA, Solomon BJ, Sequist LV, Gainor JF and Heist RS: Lung cancer. Lancet. 398:535–554. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Bade BC and Dela Cruz CS: Lung cancer 2020: Epidemiology, etiology, and prevention. Clin Chest Med. 41:1–24. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu Y, Ma K, Ye Y, Tang J and Zhu J: Long non-coding RNA LINRIS is upregulated in non-small cell lung cancer and its silencing inhibits cell proliferation by suppressing microRNA-10a maturation. Bioengineered. 13:4340–4346. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Gao Y, Zhao H and Mu L: LncRNA-KAT7 negatively regulates miR-10a through an epigenetic pathway to participate in nonsmall cell lung cancer. Cancer Biother Radiopharm. 36:441–445. 2021.PubMed/NCBI | |
|
Thrift AP: Global burden and epidemiology of Barrett oesophagus and oesophageal cancer. Nat Rev Gastroenterol Hepatol. 18:432–443. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Iriarte F, Su S, Petrov RV, Bakhos CT and Abbas AE: Surgical management of early esophageal cancer. Surg Clin North Am. 101:427–441. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
He N, Xiang L, Chen L, Tong H, Wang K, Zhao J, Song F, Yang H, Wei X and Jiao Z: The role of long non-coding RNA FGD5-AS1 in cancer. Bioengineered. 13:11026–11041. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Feng B, Wang G, Liang X, Wu Z, Wang X, Dong Z, Guo Y, Shen S, Liang J and Guo W: LncRNA FAM83H-AS1 promotes oesophageal squamous cell carcinoma progression via miR-10a-5p/Girdin axis. J Cell Mol Med. 24:8962–8976. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J and Finn RS: Hepatocellular carcinoma. Nat Rev Dis Primers. 7:62021. View Article : Google Scholar : PubMed/NCBI | |
|
Anwanwan D, Singh SK, Singh S, Saikam V and Singh R: Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer. 1873:1883142020. View Article : Google Scholar : PubMed/NCBI | |
|
Li H, Zhao X, Li C, Sheng C and Bai Z: Integrated analysis of lncRNA-associated ceRNA network reveals potential biomarkers for the prognosis of hepatitis B virus-related hepatocellular carcinoma. Cancer Manag Res. 11:877–897. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Liu J, Lv Y, Zhang C and Guo S: LncRNA meg3 suppresses hepatocellular carcinoma in vitro and vivo studies. Am J Transl Res. 11:4089–4099. 2019.PubMed/NCBI | |
|
Wu Y, Zhou Y, Huan L, Xu L, Shen M, Huang S and Liang L: LncRNA MIR22HG inhibits growth, migration and invasion through regulating the miR-10a-5p/NCOR2 axis in hepatocellular carcinoma cells. Cancer Sci. 110:973–984. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Gao J, Dai C, Yu X, Yin XB and Zhou F: Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway. J Cell Biochem. 122:86–99. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu H, Du F and Cao C: Restoration of circPSMC3 sensitizes gefitinib-resistant esophageal squamous cell carcinoma cells to gefitinib by regulating miR-10a-5p/PTEN axis. Cell Biol Int. 45:107–116. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Dekker E, Tanis PJ, Vleugels JLA, Kasi PM and Wallace MB: Colorectal cancer. Lancet. 394:1467–1480. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Fan A, Wang B, Wang X, Nie Y, Fan D, Zhao X and Lu Y: Immunotherapy in colorectal cancer: Current achievements and future perspective. Int J Biol Sci. 17:3837–3849. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Ren W, Chen S, Liu G, Wang X, Ye H and Xi Y: TUSC7 acts as a tumor suppressor in colorectal cancer. Am J Transl Res. 9:4026–4035. 2017.PubMed/NCBI | |
|
Yang RQ, Jin ZZ, Jiang SY and Jin YJ: LncRNA GAS5 interacts with MicroRNA-10b to inhibit cell proliferation and migration and induces apoptosis in colorectal cancer. Comput Math Methods Med. 2022:49968702022.PubMed/NCBI | |
|
Wu Y, Cong L, Chen W, Wang X and Qiu F: lncRNA LINC00963 downregulation regulates colorectal cancer tumorigenesis and progression via the miR-10b/FGF13 axis. Mol Med Rep. 23:2112021. View Article : Google Scholar : PubMed/NCBI | |
|
Li F, Aljahdali IAM, Zhang R, Nastiuk KL, Krolewski JJ and Ling X: Kidney cancer biomarkers and targets for therapeutics: Survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma. J Exp Clin Cancer Res. 40:2542021. View Article : Google Scholar : PubMed/NCBI | |
|
Yong C, Stewart GD and Frezza C: Oncometabolites in renal cancer. Nat Rev Nephrol. 16:156–172. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Dong D, Mu Z, Wei N, Sun M, Wang W, Xin N, Shao Y and Zhao C: Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway. Biomed Pharmacother. 111:917–925. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Xu Z, Ye J, Bao P, Wu Q, Xie F and Li P: Long non-coding RNA SNHG3 promotes the progression of clear cell renal cell carcinoma via regulating BIRC5 expression. Transl Cancer Res. 10:4502–4513. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Luo Y, Yang J, Yu J, Liu X, Yu C, Hu J, Shi H and Ma X: Long non-coding RNAs: Emerging roles in the immunosuppressive tumor microenvironment. Front Oncol. 10:482020. View Article : Google Scholar : PubMed/NCBI | |
|
Liu RJ, Xu ZP, Li S, Yu JJ, Xu B and Chen M: Identification a ceRNA (XIST/miR-10a-5p/SERPINE1) axis as a prognostic biomarker in kidney renal clear cell carcinoma. Research Square. 2021. | |
|
Liu RJ, Xu ZP, Li SY, Yu JJ, Feng NH, Xu B and Chen M: BAP1-related ceRNA (NEAT1/miR-10a-5p/SERPINE1) promotes proliferation and migration of kidney cancer cells. Front Oncol. 12:8525152022. View Article : Google Scholar : PubMed/NCBI | |
|
Tan P, Chen H, Huang Z, Huang M, Du Y, Li T, Chen Z, Liu Y and Fu W: MMP25-AS1/hsa-miR-10a-5p/SERPINE1 axis as a novel prognostic biomarker associated with immune cell infiltration in KIRC. Mol Ther Oncolytics. 22:307–325. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Liang Y, Zhang H, Song X and Yang Q: Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets. Semin Cancer Biol. 60:14–27. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Coughlin SS: Epidemiology of breast cancer in women. Adv Exp Med Biol. 1152:9–29. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Matamala N, Vargas MT, González-Cámpora R, Miñambres R, Arias JI, Menéndez P, Andrés-León E, Gómez-López G, Yanowsky K, Calvete-Candenas J, et al: Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection. Clin Chem. 61:1098–1106. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Lu Y, Ding Y, Wei J, He S, Liu X, Pan H, Yuan B, Liu Q and Zhang J: Anticancer effects of traditional Chinese medicine on epithelial-mesenchymal transition (EMT) in breast cancer: Cellular and molecular targets. Eur J Pharmacol. 907:1742752021. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Z, Huang L, Sun L, Nie H, Liang Y, Huang J, Wu F and Hu X: Ecust004 suppresses breast cancer cell growth, invasion, and migration via EMT regulation. Drug Des Devel Ther. 15:3451–3461. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Wang B, Zhang Y, Zhang H, Lin F, Tan Q, Qin Q, Bao W, Liu Y, Xie J and Zeng Q: Long intergenic non-protein coding RNA 324 prevents breast cancer progression by modulating miR-10b-5p. Aging (Albany NY). 12:6680–6699. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang D, Wang Z, Zhang L and Sun S: LncRNA PDCD4-AS1 alleviates triple negative breast cancer by increasing expression of IQGAP2 via miR-10b-5p. Transl Oncol. 14:1009582021. View Article : Google Scholar : PubMed/NCBI | |
|
Berek JS, Renz M, Kehoe S, Kumar L and Friedlander M: Cancer of the ovary, fallopian tube, and peritoneum: 2021 Update. Int J Gynaecol Obstet. 155 (Suppl 1):S61–S85. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Tan WX, Sun G, Shangguan MY, Gui Z, Bao Y, Li YF and Jia ZH: Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling. Sci Rep. 10:147682020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu Y, Mo M, Wei Y, Wu J, Pan J, Freedland SJ, Zheng Y and Ye D: Epidemiology and genomics of prostate cancer in Asian men. Nat Rev Urol. 18:282–301. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Adamaki M and Zoumpourlis V: Prostate cancer biomarkers: From diagnosis to prognosis and precision-guided therapeutics. Pharmacol Ther. 228:1079322021. View Article : Google Scholar : PubMed/NCBI | |
|
Liu S, Wang L, Li Y, Cui Y, Wang Y and Liu C: Long non-coding RNA CHRF promotes proliferation and mesenchymal transition (EMT) in prostate cancer cell line PC3 requiring up-regulating microRNA-10b. Biol Chem. Jul 9–2019.(Epub ahead of print). | |
|
Li WJ, Li G, Liu ZW, Chen ZY and Pu R: LncRNA LINC00355 promotes EMT and metastasis of bladder cancer cells through the miR-424-5p/HMGA2 axis. Neoplasma. 68:1225–1235. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Li G, Zhang Y, Mao J, Hu P, Chen Q, Ding W and Pu R: lncRNA TUC338 is a potential diagnostic biomarker for bladder cancer. J Cell Biochem. 120:18014–18019. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Ye M, Gao R, Chen S, Wei M, Wang J, Zhang B, Wu S, Xu Y, Wu P, Chen X, et al: Downregulation of MEG3 and upregulation of EZH2 cooperatively promote neuroblastoma progression. J Cell Mol Med. 26:2377–2391. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou X, Lu H, Li F, Han L, Zhang H, Jiang Z, Dong Q and Chen X: LncRNA cancer susceptibility candidate (CASC7) upregulates phosphatase and tensin homolog by downregulating miR-10a to inhibit neuroblastoma cell proliferation. Neuroreport. 31:381–386. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Tan AC, Ashley DM, López GY, Malinzak M, Friedman HS and Khasraw M: Management of glioblastoma: State of the art and future directions. CA Cancer J Clin. 70:299–312. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Uddin MS, Mamun AA, Alghamdi BS, Tewari D, Jeandet P, Sarwar MS and Ashraf GM: Epigenetics of glioblastoma multiforme: From molecular mechanisms to therapeutic approaches. Semin Cancer Biol. 83:100–120. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Hao SC, Ma H, Niu ZF, Sun SY, Zou YR and Xia HC: hUC-MSCs secreted exosomes inhibit the glioma cell progression through PTENP1/miR-10a-5p/PTEN pathway. Eur Rev Med Pharmacol Sci. 23:10013–10023. 2019.PubMed/NCBI | |
|
Ding Y, Wang J, Zhang H and Li H: Long noncoding RNA-GAS5 attenuates progression of glioma by eliminating microRNA-10b and Sirtuin 1 in U251 and A172 cells. Biofactors. 46:487–496. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Shang C, Tang W, Pan C, Hu X and Hong Y: Long non-coding RNA TUSC7 inhibits temozolomide resistance by targeting miR-10a in glioblastoma. Cancer Chemother Pharmacol. 81:671–678. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Saleh K, Khalifeh-Saleh N and Kourie HR: Acute myeloid leukemia transformed to a targetable disease. Future Oncol. 16:961–972. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Yuan Z and Wang W: LncRNA SNHG4 regulates miR-10a/PTEN to inhibit the proliferation of acute myeloid leukemia cells. Hematology. 25:160–164. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Petty RD, Dahle-Smith A, Stevenson DAJ, Osborne A, Massie D, Clark C, Murray GI, Dutton SJ, Roberts C, Chong IY, et al: Gefitinib and EGFR gene copy number aberrations in esophageal cancer. J Clin Oncol. 35:2279–2287. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Kang J, Guo Z, Zhang H, Guo R, Zhu X and Guo X: Dual inhibition of EGFR and IGF-1R signaling leads to enhanced antitumor efficacy against esophageal squamous cancer. Int J Mol Sci. 23:103822022. View Article : Google Scholar : PubMed/NCBI | |
|
Fu X, Cui G, Liu S and Zhao S: Linc01014 regulates gefitinib resistance in oesophagus cancer via EGFR-PI3K-AKT-mTOR signalling pathway. J Cell Mol Med. 24:1670–1675. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang K, Fan R, Zhao D, Liu Z, Yang Z, Liu J, Zhang S, Rao S, Wang Y and Wan L: CircATIC inhibits esophageal carcinoma progression and promotes radiosensitivity by elevating RHCG through sponging miR-10-3p. Thorac Cancer. 13:934–946. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Lu C, Jiang W, Hui B, Rong D, Fu K, Dong C, Tang W and Cao H: The circ_0021977/miR-10b-5p/P21 and P53 regulatory axis suppresses proliferation, migration, and invasion in colorectal cancer. J Cell Physiol. 235:2273–2285. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Liu M: CircFAT1 is overexpressed in colorectal cancer and suppresses cancer cell proliferation, invasion and migration by increasing the maturation of miR-10a. Cancer Manag Res. 13:4309–4315. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Luo L, Gao YQ and Sun XF: Circular RNA ITCH suppresses proliferation and promotes apoptosis in human epithelial ovarian cancer cells by sponging miR-10a-α. Eur Rev Med Pharmacol Sci. 22:8119–8126. 2018.PubMed/NCBI | |
|
Teng F, Xu J, Zhang M, Liu S, Gu Y, Zhang M, Wang X, Ni J, Qian B, Shen R and Jia X: Comprehensive circular RNA expression profiles and the tumor-suppressive function of circHIPK3 in ovarian cancer. Int J Biochem Cell Biol. 112:8–17. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Raglan O, Kalliala I, Markozannes G, Cividini S, Gunter MJ, Nautiyal J, Gabra H, Paraskevaidis E, Martin-Hirsch P, Tsilidis KK and Kyrgiou M: Risk factors for endometrial cancer: An umbrella review of the literature. Int J Cancer. 145:1719–1730. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Urick ME and Bell DW: Clinical actionability of molecular targets in endometrial cancer. Nat Rev Cancer. 19:510–521. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Yang P, Yun K and Zhang R: CircRNA circ-ATAD1 is downregulated in endometrial cancer and suppresses cell invasion and migration by downregulating miR-10a through methylation. Mamm Genome. 32:488–494. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Cui C, Yang J, Li X, Liu D, Fu L and Wang X: Functions and mechanisms of circular RNAs in cancer radiotherapy and chemotherapy resistance. Mol Cancer. 19:582020. View Article : Google Scholar : PubMed/NCBI | |
|
Kim MK, Cho KJ, Kwon GY, Park SI, Kim YH, Kim JH, Song HY, Shin JH, Jung HY, Lee GH, et al: ERCC1 predicting chemoradiation resistance and poor outcome in oesophageal cancer. Eur J Cancer. 44:54–60. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Tan S, Li D and Zhu X: Cancer immunotherapy: Pros, cons and beyond. Biomed Pharmacother. 124:1098212020. View Article : Google Scholar : PubMed/NCBI | |
|
van den Bulk J, Verdegaal EM and de Miranda NF: Cancer immunotherapy: Broadening the scope of targetable tumours. Open Biol. 8:1800372018. View Article : Google Scholar : PubMed/NCBI |
